NCT02440139

Brief Summary

STUDY DESIGN: This is a retrospective, multi-reader, multi-case, (MRMC) randomized reader study. OBJECTIVE: Primary: The primary objective of this clinical study is to prove that a user aided with ClearRead CT InSight (CRCTI) is superior to the unaided reader for detecting actionable lung nodules. Secondary: The secondary objective of this clinical study is to prove that the reader's reading time is not significantly increased when aided with CRCTI. NUMBER OF SUBJECTS: Retrospective CT studies from approximately 300 patients will be included in the study. Approximately 100 true positive cases and 200 normal cases. NUMBER OF READERS: A reader study with at least ten (10) participating radiologists (US Board Certified) will be conducted. PRIMARY ENDPOINTS: Scores given by the radiologists with and without ClearRead CT Insight will be recorded and compared to the true status of the study-cases. The frequency of the scores for each method (Unaided, Aided) will be tabulated and LROC curves constructed along with sensitivity, specificity, PPV, NPV and clinical actions. Additionally, machine nodule detection rate and false positives per patient on normal cases will be measured. PATIENT POPULATION : The study will target approximately one hundred (100) patients whose CT nodules were shown to be cancer and two hundred (200) normal patients. The patient population will be consistent with the national lung cancer screening protocols.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable lung-cancer

Timeline
Completed

Started Apr 2015

Typical duration for not_applicable lung-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

April 15, 2015

Completed
27 days until next milestone

First Posted

Study publicly available on registry

May 12, 2015

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
3.6 years until next milestone

Results Posted

Study results publicly available

October 4, 2021

Completed
Last Updated

November 4, 2021

Status Verified

November 1, 2021

Enrollment Period

2.4 years

First QC Date

April 15, 2015

Results QC Date

March 13, 2020

Last Update Submit

November 2, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Comparing the Detection Accuracy, Sensitivity, and Specificity of Clinically Actionable Lung Nodules

    The detection rates in accuracy, sensitivity, and specificity on clinically actionable lung nodules were computed and compared for Aim 1 (baseline) and Arm 2 (study participants were aided with ClearRead CT software) studies.

    4 months

  • Comparing LROC Curve in the Detection of Clinically Actionable Lung Nodules Among Normal

    The areas under location-specific Receiver Operating Characteristic (LROC) curves were computed and compared for Aim 1 (baseline) and Aim 2 (study participants were aided with ClearRead CT software).

    4 months

Secondary Outcomes (1)

  • Average Reading Time Per Case

    4 months

Study Arms (2)

Arm 1

NO INTERVENTION

Participating radiologists will perform clinical reading on \~300 cases. They will mark all locations of concern (clinically actionable nodules) on conventional thoracic CT images. Computer will measure time, readers score regions according to action and suspiciousness.

Arm 2

ACTIVE COMPARATOR

Participating radiologists will perform clinical reading on \~300 cases. They will mark all locations of concern (clinically actionable nodules) on thoracic CT images aided by ClearRead CT Insight software as the intervention. Computer will measure time, readers score regions according to action and suspiciousness.

Device: ClearRead CT Insight

Interventions

During the second reading session (concurrent read), the radiologist will be presented with a standard appearing CT with CADe marks placed and the vessel suppressed same slice with the vessel suppressed view as the intervention. The second image, vessel suppressed, will be grayed out until the radiologist move the mouse to the second panel. The radiologist will mark locations. These may or may not correspond to the locations of the CAD markers. As before, the radiologist will assign a level of suspicious to each mark and indicate the need, if any, of an additional diagnostic action (CT Follow-up, Contrast CT, PET-CT, or Biopsy).

Arm 2

Eligibility Criteria

Age55 Years - 77 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A thoracic CT case that is associated or with a feature of the following:
  • Asymptomatic patients age 55 - 77 with history of smoking
  • Primary Lung Cancer
  • Biopsy Proven (LuRADS 5) with radiology report
  • Screen detected event plus 1 prior CT. 2 year of prior CTs is preferred, if available.
  • \<= 3mm slice spacing, no gaps
  • Use standard reconstruction kernels
  • Maximum of 5 nodules per image
  • Nodules must be 5-20mm in size
  • With or without contrast

You may not qualify if:

  • No Acute pneumothorax
  • Both lungs must be fully visible within the field of view
  • Apices cannot be cropped
  • No excessive motion artifacts
  • Symptomatic patients with co-morbidities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arlington Innovation Center: Health Resaerch

Arlington, Virginia, 22203, United States

Location

Related Publications (6)

  • Beyer F, Zierott L, Fallenberg EM, Juergens KU, Stoeckel J, Heindel W, Wormanns D. Comparison of sensitivity and reading time for the use of computer-aided detection (CAD) of pulmonary nodules at MDCT as concurrent or second reader. Eur Radiol. 2007 Nov;17(11):2941-7. doi: 10.1007/s00330-007-0667-1. Epub 2007 May 22.

    PMID: 17929026BACKGROUND
  • Dorfman DD, Berbaum KS, Metz CE. Receiver operating characteristic rating analysis. Generalization to the population of readers and patients with the jackknife method. Invest Radiol. 1992 Sep;27(9):723-31. No abstract available.

    PMID: 1399456BACKGROUND
  • Foti G, Faccioli N, D'Onofrio M, Contro A, Milazzo T, Pozzi Mucelli R. Evaluation of a method of computer-aided detection (CAD) of pulmonary nodules with computed tomography. Radiol Med. 2010 Sep;115(6):950-61. doi: 10.1007/s11547-010-0556-6. Epub 2010 Jun 23. English, Italian.

    PMID: 20574707BACKGROUND
  • Matsumoto S, Ohno Y, Aoki T, Yamagata H, Nogami M, Matsumoto K, Yamashita Y, Sugimura K. Computer-aided detection of lung nodules on multidetector CT in concurrent-reader and second-reader modes: a comparative study. Eur J Radiol. 2013 Aug;82(8):1332-7. doi: 10.1016/j.ejrad.2013.02.005. Epub 2013 Mar 6.

    PMID: 23480965BACKGROUND
  • Obuchowski NA. New methodological tools for multiple-reader ROC studies. Radiology. 2007 Apr;243(1):10-2. doi: 10.1148/radiol.2432060387. No abstract available.

    PMID: 17392244BACKGROUND
  • Obuchowski NA, McClish DK. Sample size determination for diagnostic accuracy studies involving binormal ROC curve indices. Stat Med. 1997 Jul 15;16(13):1529-42. doi: 10.1002/(sici)1097-0258(19970715)16:133.0.co;2-h.

    PMID: 9249923BACKGROUND

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Limitations and Caveats

This study only used a relatively low number of thoracic CT cases read by 12 radiologists. The study cases were mainly collected from the National Lung Screen Trial (NLST) lung cancer screening program. In addition, the study suffered from readers' lack of learning time of using the AI software.

Results Point of Contact

Title
Dr. ShihChung Benedict Lo
Organization
Virginia Tech

Study Officials

  • Matthew T Freedman, M.D.

    Virginia Polytechnic Institute and State University

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Professor

Study Record Dates

First Submitted

April 15, 2015

First Posted

May 12, 2015

Study Start

April 1, 2015

Primary Completion

September 1, 2017

Study Completion

March 1, 2018

Last Updated

November 4, 2021

Results First Posted

October 4, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations